Risk Management Procedure
Risk Management Procedure
Description:
This Risk Management Procedure defines how we implement, document, and maintain an ongoing ISO 14971 / EN ISO 14971 risk management process across the full device lifecycle.
-
Establish and maintain a Risk Management File (RMF) containing RMP, RA, and RMR
-
Apply the lifecycle phases: risk analysis, risk evaluation, risk control, and production/post-production monitoring
-
Define risk acceptability criteria in the Risk Management Plan (RMP) using severity and likelihood rankings
-
Use Risk Priority Number (RPN) and an acceptability scale (low / undesirable / intolerable) to evaluate risks
-
Define criteria and methods for overall residual risk acceptability and Benefit/Risk (B/R) evaluation
-
Plan and execute risk control measures and verify implementation and effectiveness
-
Collect and review production and post-market inputs (e.g., complaints, PMS, PMCF, vigilance, FSCA) to update the RMF
Your needs:
-
Risk management procedure
-
Risk management procedure for MDR decision-making
-
Reduce rework, strengthen benefit-risk justifications, and improve audit readiness
This document is used to standardise risk management activities for each device or device family, from early design through post-market monitoring, ensuring decisions are consistent, documented, and maintained over time.
It sets the rules for risk evaluation and acceptability. RPN is the numeric ranking from multiplying severity and likelihood; it matters because it helps prioritise which risks require stronger controls. Overall residual risk is the remaining cumulative risk after controls; it matters because it must remain acceptable versus the device’s benefits.
-
Maintain RMF structure and controlled identification (RMF/RMP/RA/RMR codes)
-
Define severity/likelihood criteria and quantitative thresholds where possible
-
Perform B/R evaluation via labeling review and/or expert review (linked to the CER)
-
Apply AFAP risk reduction and assess risks introduced by controls
-
Verify control effectiveness using testing, V&V, process validation, and clinical data
At Lexqara, we help you implement ISO 14971-aligned workflows, build audit-ready RMFs, and connect risk management to design controls, clinical documentation, PMS/PMCF, and regulatory strategy without overburdening teams. Get templates in our Resource Center and explore our Regulatory Strategy support. For institutional context, consult EU MDR (Regulation (EU) 2017/745).
Download the template or request a short gap assessment.
200,00 €